Share on

Europe Cell Counting Market Research Report – Segmented By Product, Consumables, End User & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Size, Share, Trends, Growth, Forecasts (2023 to 2027)

Published: March, 2023
ID: 5767
Pages: 145
Formats: report pdf report excel report power bi report ppt

Europe Cell Counting Market Size (2023 to 2028)

The Europe cell counting market was valued at USD 0.31 billion in 2023. This value is further estimated to be growing at a CAGR of 6.8% between 2023 to 2028 and will be worth USD 0.43 billion by 2028.

Cell counters are becoming more widely used in various applications, including research, diagnostics, and industry. Cell counting instruments are increasingly being used in multiple fields of study, including cancer biology, immunology, and neuroscience, and the market is expected to grow exponentially. In addition, as the number of chronic diseases rise, the demand for tools increases.

The increased incidence of target diseases such as HIV, measles, and diphtheria and chronic diseases such as cancer and other blood disorders is primarily driving the European cell counting market expansion. According to the World Health Organization (WHO), almost 7.9 million people in Europe were infected with HIV in 2018. Most of this prevalence has been discovered in poor and middle-income nations. Furthermore, the government's increasing financing for cell counting research boosts industry growth. The market expansion is supplemented by inspiring attitudes toward stem cell research, increased funding, and widespread awareness of stem cells.

The rising frequency of AIDS and cancer is one of the primary factors driving the worldwide cell counting industry. Cell counting ensures intra-tumor heterogeneity, an essential step in tracking cancer growth in the patient's body. However, many people are hesitant to spend money on cell counting methods for medical or research purposes due to the high costs of the apparatus, equipment, and procedures. Furthermore, most countries have underdeveloped healthcare infrastructure and antiquated technology, severely hindering cell counting growth. Morseverely hindering cell counting growthcarcity of competent personnel.

The expansion of the market in Europe is being hampered by a scarcity of experienced professionals combined with insufficient research infrastructure, particularly in emerging markets.

This research report on the Europe cell counting market has been segmented and sub-segmented into the following categories.

By Product:

  • Instruments
  • Cell Counters
  • Hematology Analysers
  • Spectrophotometer
  • Flow Cytometer
  • Hemocytometer
  • Others

Based on the product, the spectrophotometers segment is anticipated to play the leading role in the European cell counting market during the forecast period.

By Consumables:

  • Microplates
  • Reagent
  • Assay Kits

By End User:

  • Pharmaceutical & Biotechnology Industries
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Europe is expected to have the second-highest share of the global cell counting market during the forecast period owing to the growing patient population suffering from chronic diseases and the increasing aging population. Furthermore, the European cell counting market is expected to grow in the coming years due to the rising prevalence of chronic diseases and blood-related disorders, technological advancements in this segment, and the expanding biopharmaceutical and biotechnology industries.

The UK cell counting market held a promising share of the European market in 2022 and is expected to witness a notable CAGR during the forecast period owing to an increasing number of chronic diseases and a growing number of research and development programs. In addition, growing demand for high-tech instruments in research and diagnostic applications, high incidence of target conditions, increased focus on stem cell, biomedical, and cancer research, rising prevalence of chronic diseases, and growing demand for early diagnosis and effective treatment of diseases are all contributing to this segment's large share.

The German cell counting market is predicted to register a healthy CAGR in the coming years and hold a considerable share of the European market. The rising number of stem cell, genomics, and proteomic research activities, the vast genome pool, the growing trend for research infrastructure modernization, low development costs, less complicated regulations, and increasing investments by pharmaceutical and biotechnology companies contribute to this growth.

Other countries such as Spain, Italy, and France are anticipated to witness a steady growth rate during the forecast period.

KEY MARKET PLAYERS

Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, Inc., GE Healthcare, Becton, Dickinson and Company, and PerkinElmer, Inc. are some of the noteworthy companies in the European cell counting market.

Please wait. . . . Your request is being processed

FAQ's

What is the growth rate of the Europe cell counting market?

The Europe cell counting market is estimated to grow at a CAGR of 6.8% from 2023 to 2028.

What factors are driving the growth of the Europe cell counting market?

The rising prevalence of chronic diseases, rising demand for personalized medicine, increasing investments in life sciences research, and technological advancements in cell counting instruments and software are some of the major factors driving the growth of the Europe cell counting market.

What are the major players in the Europe cell counting market?

Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Beckman Coulter, Inc., Agilent Technologies, Inc., and Becton, Dickinson and Company are some of the notable players in the Europe cell counting market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample